See more with Compass+
You are currently viewing the free version of this study. To access the full study and more leading research on the health economy, subscribe to Compass+.
Sign Up for Compass+Develop Service Line Strategies
Analyze the Competitive Landscape
Anticipate Future Patient Needs
Identify Sites To Capture Demand
Drive Loyalty Across the Patient Journey
Leverage Price Transparency Insights
Retain Patients in Your Network
Match Provider Supply to Demand
Acquire Commercial Patients
Capture Outpatient Demand
Target High-Value HCPs
Strengthen Provider Networks
We collect and organize the industry’s most comprehensive healthcare datasets.
See demand, supply and yield across the U.S. health economy
Validated Data for 2.9M Practitioners
Episodes of Care for 300M Patients
Negotiated Rates for Any Service at Any Location
Flexible solutions to fit your specific needs and workflow
Free resources to help health economy stakeholders use our products and data
Answer Key Questions in Seconds
Health Economy Survival Strategies
Custom Enterprise-Level Analyses
Product Guides and Feature Releases
Exclusive Health Economy Insights
How We Tackle Technical Problems
Data-Driven Benchmarking Tool
Strategic guidance and commentary from our CEO, Hal Andrews
Annual fact-based analysis of trends shaping the health economy
An essential resource to survive healthcare’s negative-sum game
Develop Service Line Strategies
Analyze the Competitive Landscape
Anticipate Future Patient Needs
Identify Sites To Capture Demand
Drive Loyalty Across the Patient Journey
Leverage Price Transparency Insights
Retain Patients in Your Network
Match Provider Supply to Demand
Acquire Commercial Patients
Capture Outpatient Demand
Target High-Value HCPs
Strengthen Provider Networks
We collect and organize the industry’s most comprehensive healthcare datasets.
See demand, supply and yield across the U.S. health economy
Validated Data for 2.9M Practitioners
Episodes of Care for 300M Patients
Negotiated Rates for Any Service at Any Location
Flexible solutions to fit your specific needs and workflow
Answer Key Questions in Seconds
Custom Enterprise-Level Analyses
Exclusive Health Economy Insights
Free resources to help health economy stakeholders use our products and data
Health Economy Survival Strategies
Product Guides and Feature Releases
How We Tackle Technical Problems
Data-Driven Benchmarking Tool
Strategic guidance and commentary from our CEO, Hal Andrews
Annual fact-based analysis of trends shaping the health economy
An essential resource to survive healthcare’s negative-sum game
In the aftermath of telehealth volumes spiking during the pandemic, a number of established companies have entered the market, joining early market entrants such as Teladoc and Amwell. The net effect, as previously written, is telehealth supply is already exceeding consumer demand.
With 38M Americans (excluding traditional Medicare) generating approximately 96M of telehealth visits during COVID-19, the demand for telehealth is limited to discrete population segments. Yet, continued growth in the supply-side of the telehealth equation would suggest many expect telehealth to substitute for a subset of in-person visit types.
With that in mind, we conducted an analysis of all-payer claims that was limited to E&M codes that offer both an in-person and virtual option. We found that 83.2% of patients that used telehealth during the pandemic still opted to receive in-person care for services offering an equivalent telehealth option (Figure 1). Moreover, the proportion of individuals who opted for in-person care increased (+3.25 percentage points) in 2021. The ratio of in-person to telehealth visits is consistent (+/- 2 percentage points) across Medicare, Medicaid, and commercially insured patients.
Similar to what we see in industries with abundant choice, consumers also want omni-channel options in healthcare. For example, those who order groceries online still shop at brick-and-mortar stores, just less often; the same can be said for telehealth. Whereas much of the current discussion in the industry has been around telehealth as a substitute good for select services, we must also consider that our patients, and ultimately consumers, will always want the option to flex between modalities for a particular service.
Among the current market of telehealth providers, Walmart’s entry, with the acquisition of MeMD, is particularly noteworthy. Given the brand’s significant physical footprint (Figure 2), Walmart’s expansion into telehealth signals a commitment to integrated, omni-channel healthcare delivery. With more than 1,000 existing locations in the fastest growing states and plans to establish more than 4,000 primary care "supercenters" across the country, Walmart is uniquely positioned to provide consumers with an omni-channel approach to primary care services.
As the number of tele-enabled providers grows, we will inevitably see more suppliers competing for smaller, niche segments of corresponding demand. Thus, providers that can offer both tele- and in-person care delivery capabilities will earn a greater share of care.
You are currently viewing a free preview of our premium studies. To receive new studies weekly, upgrade to Compass+.
Sign UpYou are currently viewing the free version of this study. To access the full study and more leading research on the health economy, subscribe to Compass+.
Sign Up for Compass+